Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions

Bruton's tyrosine kinase (BTK), a member of the Tec kinase family, is critically involved in a range of immunological pathways. The clinical application of BTK inhibitors for B‐cell malignancies has proven successful, and there is strong rationale for the potential benefits of BTK inhibitors in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes‐Bastos, Pedro, Brasileiro, Ana, Kolkhir, Pavel, Frischbutter, Stefan, Scheffel, Jörg, Moñino‐Romero, Sherezade, Maurer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545595/
https://www.ncbi.nlm.nih.gov/pubmed/35175630
http://dx.doi.org/10.1111/all.15261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545595/
https://www.ncbi.nlm.nih.gov/pubmed/35175630
http://dx.doi.org/10.1111/all.15261

Ejemplares similares